1. Home
  2. MDRR vs KTTA Comparison

MDRR vs KTTA Comparison

Compare MDRR & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medalist Diversified REIT Inc.

MDRR

Medalist Diversified REIT Inc.

HOLD

Current Price

$11.62

Market Cap

18.3M

Sector

Real Estate

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

N/A

Current Price

$0.50

Market Cap

18.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDRR
KTTA
Founded
2015
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
18.1M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
MDRR
KTTA
Price
$11.62
$0.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
2.8K
207.9K
Earning Date
03-02-2026
05-14-2026
Dividend Yield
2.43%
N/A
EPS Growth
N/A
77.07
EPS
4.74
N/A
Revenue
$10,396,618.00
$486,559.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.53
N/A
Revenue Growth
6.79
3130.37
52 Week Low
$9.47
$0.28
52 Week High
$14.52
$2.06

Technical Indicators

Market Signals
Indicator
MDRR
KTTA
Relative Strength Index (RSI) 47.67 44.82
Support Level $11.01 $0.48
Resistance Level $12.23 $0.52
Average True Range (ATR) 0.35 0.04
MACD -0.00 -0.01
Stochastic Oscillator 23.68 11.30

Price Performance

Historical Comparison
MDRR
KTTA

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: